Mindrank AI CEO on Business Strategy, AI Drug Discovery
Share
Niu Zhangming, Founder and CEO at AI biotech firm Mindrank AI, discusses the company's business strategy and the role of AI in drug discovery. He speaks with Minmin Low on the sidelines of the Asia Innovation and Technology Enterprises Going Global Summit in Hong Kong.
More from Australia
The equities fueling the next infrastructure supercycle
Crypto networks collide with sanctions in a fight for financial access
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027
Celsius Resources updates market on US$5M dispute
Estrella Resources signs sales deal for 27,000 tonnes